云南白药 is involved in the pharmaceutical industry, focusing on the production and development of traditional Chinese medicine and health products, self-described as a leader in innovative healthcare solutions.

云南白药

Yunnan Baiyao Group Co., Ltd | 2,148 followers on LinkedIn. Yunnan Baiyao Group is a pharmaceuticals company based out of KUNMING. Yunnan Baiyao Group representatives, don’t miss out on opportunities to build relationships with members on LinkedIn. Claim your page, write a simple description, and share content to attract followers that can lead to new customers, brand fans, and future employees.

Healthcare Strategist and Investor

Yuan (Eric) Yan

Tax professional

Nick (Jiapeng) Li

GM MEA - Yunnan Baiyao Group

Rudolph Liu

Marketing Manager

ZheHua ZHANG

Yunnan Baiyao Group Co., Ltd

Metric
Company Name	云南白药
Symbol
MSH ID	CN:COM:YUNNANBAIYAO
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Pharmaceuticals
Country	CN
Stage
Employee Count
Website	yunnanbaiyao.com.cn
LinkedIn	yunnan-baiyao-group-co-ltd
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM

CN:COM:YUNNANBAIYAO

云南白药

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue